|
Market Closed -
Bombay S.E.
14:02:30 01/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 422.05 INR | -1.97% |
|
-1.79% | +2.48% |
| 09-27 | Aarti Drugs Limited Announces Board Appointments | CI |
| 09-26 | Aarti Drugs Limited Appoints Shri Adhish Prakash Patil as Managing Director | CI |
| Market Cap | 38.52B 401M 356M 332M 303M 571M 577M 4.02B 1.56B 19.69B 1.5B 1.47B 63.2B | P/E 2027 * |
-
| P/E 2028 * | 15.1x |
|---|---|---|---|---|---|
| Enterprise Value | 38.52B 401M 356M 332M 303M 571M 577M 4.02B 1.56B 19.69B 1.5B 1.47B 63.2B | EV / Sales 2027 * |
1.31x | EV / Sales 2028 * | 1.18x |
| Free-Float |
40.44% | Yield 2027 * |
1.4% | Yield 2028 * | 1.66% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| AARTIDRUGS | Delayed | |
NSE India S.E.
| AARTIDRUGS | Delayed |
Last Transcript: Aarti Drugs Limited
| 28/12/22 | Aarti Drugs : Loss of Share Certificates | PU |
| 10/07/22 | Aarti Drugs : Newspaper Advertisements | PU |
| 1 day | -1.97% | ||
| 1 week | -1.79% | ||
| Current month | -1.97% | ||
| 1 month | -1.04% | ||
| 3 months | +9.38% | ||
| 6 months | +19.88% | ||
| Current year | +2.48% |
| 1 week | 415 |  | 443.4 |
| 1 month | 410.2 | | 449.9 |
| Current year | 318.6 | | 453.2 |
| 1 year | 318.6 | | 533.6 |
| 3 years | 312.5 | | 634.9 |
| 5 years | 310.8 | | 645 |
| 10 years | 104.82 | | 1,025 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 80 | - | |
| Chief Tech/Sci/R&D Officer | - | - | |
| Compliance Officer | - | 23/04/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 01/06/2007 | |
| Chairman | 80 | - | |
| Director/Board Member | 63 | 02/01/1987 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.97% | -1.79% | -14.11% | -20.81% | 401M | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -0.88% | -3.41% | +22.05% | +50.93% | 369.76B | |
| Weighted average by Cap. | -0.60% | -3.33% | +29.07% | +71.14% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 29.45B 306M 272M 254M 232M 437M 441M 3.07B 1.19B 15.06B 1.15B 1.13B 48.32B | 32.69B 340M 302M 282M 257M 485M 489M 3.41B 1.32B 16.71B 1.28B 1.25B 53.63B |
| Net income | 2.15B 22.39M 19.89M 18.56M 16.92M 31.91M 32.21M 225M 87.05M 1.1B 84.05M 82.22M 3.53B | 2.55B 26.48M 23.53M 21.96M 20.02M 37.75M 38.11M 266M 103M 1.3B 99.43M 97.28M 4.18B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | ₹422.05 | -1.97% | 11,210 |
| 30/09/26 | ₹430.55 | -0.13% | 6,887 |
| 29/09/26 | ₹431.10 | +0.48% | 23,316 |
| 28/09/26 | ₹429.05 | -0.16% | 14,114 |
| 25/09/26 | ₹429.75 | -1.78% | 7,995 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AARTIDRUGS Stock
Select your edition
All financial news and data tailored to specific country editions
